OmniComm Systems' Awarded Four Clinical Trials from US Biotechnology Company

Published on: 

Company News Release

OmniComm Systems

announced that its TrialMaster suite of applications and IVRS technology has been chosen by a biotechnology company to manage their clinical data management and randomization needs for four key clinical trials. All four studies, leveraging OmniComm's Software-as-a-Service (SaaS) rapid-deployment model, will be put into production by the end of May.

OmniComm has also recently become a Society for Clinical Data Management CCDM partner, an achievement that is bestowed upon companies that are committed to quality clinical data management and Certified Clinical Data Manager (CCDM) credentialing.  Qualifying companies must have at least 10 certified CCDMs or 25% of CDMs must have achieved certification.